Antiretroviral therapy

ABSTRACT In its first performance report combining key performance indicators and strategy implementation reporting, the Global Fund has reported several items of good news to the 40th Board: 101% of the target for the Fifth Replenishment has been pledged and the Secretariat is forecasting that all pledges will be fulfilled; investments are better aligned to needs and national strategic plans; and country programs have increased funds absorption and provided better disaggregated data. However, enduring problems remain in service delivery and coverage of key populations.

ABSTRACT The Global Fund’s Results Report 2018, published on 12 September, is the first such report to use a revised methodology for tracking and reporting impact and results achieved by the Global Fund partnership. The report records large increases in the numbers of lives saved and people treated for the three diseases.

ABSTRACT Implementing the scale-up for HIV treatment and prevention called for in the Vancouver Consensus will be very costly. It is obvious that the estimated resource needs for the next Global Fund replenishment for HIV, TB and malaria will be much higher than the $87 billion that was estimated for the last replenishment in 2013. The Fund will release its resource needs estimate for the next replenishment before the end of this year.

ABSTRACT According to the Global Fund’s “Update on Results and Impact” report, significant progress has been achieved in providing antiretroviral therapy and preventing mother-to-child transmission of HIV (PMTCT), but low antenatal care coverage and other health systems–related and gender-related challenges are hampering further progress.